Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Onvansertib (NMS-P937)

Product Specifications

CAS Number

1034616-18-6

Synonyms

PCM-075, NMS1286937

Target

PLK

Applications

Cell Cycle

Smiles

CN1CCN (CC1) C2=CC (=C (C=C2) OC (F) (F) F) NC3=NC=C4CCC5=C (C4=N3) N (N=C5C (=O) N) CCO

Molecular Formula

C24H27F3N8O3

Additionnal Information

Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosis in cancer cell lines and inhibits tumor growth. Phase 1.

Storage Conditions

2 years -80 in solvent

More Discoveries

Explore Other Products

Browse additional items from our catalog

SRY (Acetyl Lys136) Antibody
D12319-01 50 μL

SRY (Acetyl Lys136) Antibody

Sign In for Pricing
View Details
SRY (Acetyl Lys136) Antibody
D12319-02 100 µL

SRY (Acetyl Lys136) Antibody

Sign In for Pricing
View Details
Recombinant Human CD85i/LILRA1 Protein, N-His
orb3154151-01 50 µg

Recombinant Human CD85i/LILRA1 Protein, N-His

Sign In for Pricing
View Details
Recombinant Human CD85i/LILRA1 Protein, N-His
orb3154151-02 100 µg

Recombinant Human CD85i/LILRA1 Protein, N-His

Sign In for Pricing
View Details
Recombinant Human CD85i/LILRA1 Protein, N-His
orb3154151-03 1 mg

Recombinant Human CD85i/LILRA1 Protein, N-His

Sign In for Pricing
View Details
IPI-145 (Duvelisib, INK1197) 100mg
A12422-100 100 mg

IPI-145 (Duvelisib, INK1197) 100mg

Sign In for Pricing
View Details